These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5044666)

  • 1. [Antineoplastic effect of cyclophosphane as a function of its administration].
    Gordienko SP; Botsmanov KB
    Eksp Khir Anesteziol; 1972; 17(2):50-2. PubMed ID: 5044666
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
    Focan C; Barbason H; Betz EH
    Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological parameters of a standardized tumor model for chemotherapeutical and toxicological testing (author's transl)].
    Fichtner I; Arnold W; Pehl E
    Arch Geschwulstforsch; 1979; 49(5):391-407. PubMed ID: 518249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extract of Eleutherococcus senticosus maxim and the therapeutic activity of cyclophosphane, ethymidine, and benzo-TEPA].
    Monakhov BV
    Vopr Onkol; 1967; 13(8):94-7. PubMed ID: 5601555
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of cyclophosphamide-treated leukaemia cells.
    Kawalec M; Jakóbisiak M; Skórski T; Kawiak J
    Folia Biol (Praha); 1982; 28(5):334-43. PubMed ID: 6816636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant inhibition of tumor-associated inflammatory responses and rapid enhancement of cyclophosphamide-induced tumor regression by hydrocortisone.
    Evans R; Eidlen DM
    Cancer Res; 1982 Nov; 42(11):4437-42. PubMed ID: 7127285
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of cyclophosphane on tumor cell division].
    Kiseleva EG
    Vopr Onkol; 1971; 17(5):74-8. PubMed ID: 5138546
    [No Abstract]   [Full Text] [Related]  

  • 10. [A study of the antitumor effectiveness of endoxan when administered in various ways].
    Zaitseva LA; Syrkin AB
    Vopr Onkol; 1969; 15(11):99-101. PubMed ID: 5368849
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the effect of a new verucarin E analog WER I on the growth of experimental neoplasms].
    Nowak HF; Jodczyk KJ; Zimnoch L; Duda D; Piotrowska-Olczak H; Rózański A
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1980; 25():175-95. PubMed ID: 6797024
    [No Abstract]   [Full Text] [Related]  

  • 12. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
    Larionov LF; Spasskaia IG
    Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
    [No Abstract]   [Full Text] [Related]  

  • 13. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of diacarb and furosemide in combination with cytostatics on the mitotic activity of tumor and intestines of rats with sarcoma 45].
    Aref'eva AK; Pashinskiĭ VG
    Farmakol Toksikol; 1977; 40(2):215-8. PubMed ID: 852564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF; Sladek NE
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of verapamil on the clastogenic effect of cyclophosphane in somatic cells from BALB/c and C57Bl/6 mice].
    Seredenin SB; Durnev AD; Nesterova EV
    Eksp Klin Farmakol; 1999; 62(2):51-4. PubMed ID: 10340131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of 5-mercapto-6-azauracil and cysteine on the toxicity of cyclophosphamide].
    Timar M; Vrejoiu G; Teodorescu M; Eneskcu L
    Farmakol Toksikol; 1968; 31(6):741-2. PubMed ID: 5756534
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronometaanalysis: circasemiseptan (3.5-day) pattern in mitotic activity of murine sarcoma after treatment with cyclophosphamide.
    Focan C; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):401-6. PubMed ID: 8555441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor properties of 1,3-oxazine derivatives. Derivatives of dihydro-1,3-oxazine condensed with an aromatic ring in position 5,6.
    Mordarski M; Chylińska JB
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):533-45. PubMed ID: 5095072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.